Balyasny Asset Management LLC Catalent, Inc. Call Options Transaction History

Balyasny Asset Management LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$44.2 - $50.2 $2.87 Million - $3.26 Million	65,000 New	65,000 $2.96 Million
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $5 Million - $8.17 Million	110,000 New	110,000 $7.23 Million
Q2 2021 Aug 16, 2021	SELL	$100.34 - $115.69 $13 Million - $15 Million	-130,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$101.51 - $125.27 $13.2 Million - $16.3 Million	130,000 New	130,000 $13.7 Million
Q3 2020 Nov 16, 2020	SELL	$72.74 - $92.5 $14.5 Million - $18.5 Million	-200,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$48.02 - $79.04 $9.6 Million - $15.8 Million	200,000 New	200,000 $14.7 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.